Area of research
Infectious Diseases · Virology
Research interest
Research interests include Medicine, Efavirenz, Nevirapine, Human immunodeficiency virus (HIV), Emtricitabine, and Placebo.
Safety, Tolerability, and Pharmacokinetics of Long-Acting Broadly Neutralizing HIV-1 Monoclonal Antibody VRC07–523LS in Newborn Infants Exposed to HIV-1
Safety and Immune Responses Following Anti-PD-1 Monoclonal Antibody Infusions in Healthy Persons With Human Immunodeficiency Virus on Antiretroviral Therapy
Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3–36 months with HIV infection
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1
Nevirapine versus Ritonavir-Boosted Lopinavir for HIV-Infected Children